With a strong track record in technology and healthcare investments, the fund manager has executed over 30 deals across North America and Europe. Emphasizing a data-driven approach, they focus on growth-stage companies poised for significant disruption. Notably, their strategic style has led to several successful exits, highlighting their ability to identify and nurture high-potential ventures. Their expertise in thematic investing positions them well to capitalize on emerging market trends.